Related Experiment Videos
Penicillin-resistant and -intermediate Streptococcus pneumoniae in Saudi Arabia
A M Shibl1, A M Al Rasheed, A M Elbashier
1King Saud University, Riyadh, Saudi Arabia.
Journal of Chemotherapy (Florence, Italy)
|May 2, 2000
Summary
Antibiotic resistance in Streptococcus pneumoniae (S. pneumoniae) is rising in Saudi Arabia. This study found significant penicillin and multiple-drug resistance, necessitating improved diagnostic practices and antibiotic stewardship.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Streptococcus pneumoniae (S. pneumoniae) is a leading cause of bacterial infections worldwide.
- Antibiotic resistance in S. pneumoniae poses a significant public health threat.
- Data on pneumococcal resistance patterns in Saudi Arabia are crucial for guiding treatment strategies.
Purpose of the Study:
- To analyze the antibiotic susceptibility profile of S. pneumoniae isolates from Saudi Arabia.
- To determine the prevalence of resistance to key antibiotics, including penicillin.
- To identify associations between resistance patterns and inform public health interventions.
Main Methods:
- Analysis of antibiotic susceptibility testing for approximately 400 S. pneumoniae isolates.
- Isolates were collected from various clinical specimens across different regions of Saudi Arabia.
- Minimum Inhibitory Concentrations (MICs) were determined for penicillin and other antibiotics.
Main Results:
- Overall, 6.2% of S. pneumoniae isolates exhibited penicillin resistance, with 51.2% showing intermediate resistance.
- Resistance rates to cefuroxime, clarithromycin, and ceftriaxone were 14.9%, 14.8%, and 4.5%, respectively.
- Penicillin resistance was significantly associated with cefuroxime resistance (p<0.001), indicating co-resistance.
Conclusions:
- The study confirms the presence of penicillin- and multidrug-resistant S. pneumoniae strains in Saudi Arabia.
- These resistant strains demonstrate potential for transmission within the population.
- Enhanced microbiological diagnostics, susceptibility testing, and judicious antibiotic prescribing are urgently needed.